Results 191 to 200 of about 79,249 (245)

Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment. [PDF]

Discov Oncol
Sadeghloo Z, Sadeghi A.
europepmc   +1 more source

Cyclic Peptide-Polymer Conjugate Nanotubes for Delivery of SN-38 in Treatment of Colorectal Cancer Model. [PDF]

Adv Healthc Mater
Hill SK, Zeng M, Rajendrakumar SK, Dallmann R, Perrier S.   +4 more
europepmc   +1 more source

Efficacy and safety of regorafenib plus FOLFIRI with <i>UGT1A1</i> genotyping-guided irinotecan dose escalation against metastatic colorectal cancer: a multicenter, phase II, open-label, two-arm randomized controlled tria. [PDF]

Ther Adv Med Oncol
Huang CW, Chen YC, Ker TW, Lin YW, Chang TK, Su WC, Chen PJ, Tsai HL, Wang JY.   +8 more
europepmc   +1 more source

Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumors. [PDF]

Invest New Drugs
Falcón A, Ponce S, Cote GM, Gil A, Lin JJ, Bockorny B, Martínez J, Kahatt C, Martinez S, Zubiaur P, Siguero M, Cullell-Young M, Jiménez J, Zugazagoitia J, Paz-Ares L.   +14 more
europepmc   +1 more source

Impact of DNA damage repair alterations on real-world response to therapy in metastatic colorectal cancer. [PDF]

ESMO Open
Miotke L, Norton C, Rubnitz Z, Florou V, Nevala-Plagemann C, Garrido-Laguna I.   +5 more
europepmc   +1 more source

Anbenitamab in combination with chemotherapy in patients with HER2-positive gastric or gastroesophageal junction carcinoma who failed previous therapy containing trastuzumab: a multicenter, phase II study (KC-WISE 01). [PDF]

Cancer Commun (Lond)
Zhao C, Zhao J, Chen Y, Liu B, Du Y, Li C, Zhang J, Yang M, Liu Y, Bai Y, Li S, Zhang R, Ning F, Liu Y, Zou K, Zhang Q, Xie Y, An Y, Xu J.   +18 more
europepmc   +1 more source

How to Safely Deliver Stereotactic Ablative Radiotherapy With High-Dose or Multi-agent Systemic Therapy. [PDF]

Cureus
Bernard ME.
europepmc   +1 more source

The Anthocyanidins Malvidin and Cyanidin Alleviate Irinotecan-Triggered Intestinal Mucositis by Modulating Oxidative Stress and Cytokine Release. [PDF]

Int J Mol Sci
Machado GF, Pereira QC, Fagundes FL, Emílio-Silva MT, Rodrigues VP, Patiño MA, Jorge GI, Pereira JA, Martinez CAR, Hiruma-Lima CA, Dos Santos RC.   +10 more
europepmc   +1 more source

Thapsigargin enhanced chemotherapeutic sensitivity of irinotecan in the inflammation-induced colorectal cancer model in mice. [PDF]

Sci Rep
Baruah S, Bharali MK, Akhtara N, Nath JK, Rahman SS, Rasid SS, Baidya M, Khan EMMS, Mishra R.   +8 more
europepmc   +1 more source

Mechanistic Exploration of Shenling Baizhu Powder in Treating Irinotecan-Associated Diarrhea: A Study Based on Network Pharmacology and Experimental Validation. [PDF]

J Inflamm Res
Liu M, Xiong Y, Yuan J, Jin Q, Zhang JC, Shi RJ, Cheng ZQ.   +6 more
europepmc   +1 more source